Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
1(8%)
Results Posted
13%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_1
1
8%
Ph not_applicable
10
77%
Ph phase_3
2
15%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 3Large-scale testing
2(15.4%)
N/ANon-phased studies
10(76.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

13

all time

Status Distribution
Active(2)
Completed(8)
Terminated(1)
Other(2)

Detailed Status

Completed8
unknown2
Terminated1
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
1
Success Rate
88.9%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (7.7%)
Phase 32 (15.4%)
N/A10 (76.9%)

Trials by Status

terminated18%
unknown215%
active_not_recruiting18%
not_yet_recruiting18%
completed862%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
13